Johannes Laengle

Has grant

Medical University of Vienna

Austria

Research Interests

Explore related searches

Professors in Austria Professors in Immunology Immunology professors in Austria

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Assessment of DNA damage, interferon induction and tumor-infiltrating immune cells in short-term radiotherapy-treated rectal cancer

Open Date: 2017-09-01

Close Date: 2018-09-01

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Collaborators (5)

Hannes Stockinger

University Professor

Medical University of Vienna

AUSTRIA

View details

Henning Walczak

Alexander-von-Humboldt Professor of Biochemistry

University of Cologne

GERMANY

View details

Oliver Pusch

Associate Professor

Medical University of Vienna

AUSTRIA

View details

Rudolf Oehler

Associate Professor

Medical University of Vienna

AUSTRIA

View details

Nina Pilat

Associate Professor

Medical University of Vienna

AUSTRIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Johannes Laengle

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (10)

Dual Immune Checkpoint Inhibition Plus Neoadjuvant Chemoradiotherapy in Rectal Cancer

Differential prognostic roles and clinical implications of mitochondrial and genomic tRNA-derived fragments in colorectal liver metastases

Incidence and Immunopathology of Myositis in Rectal Cancer Patients Treated With Neoadjuvant Immune Checkpoint Inhibitors and Chemoradiotherapy: Findings From the CHINOREC Trial

Neoadjuvant chemoradiotherapy with ipilimumab and nivolumab in rectal cancer (CHINOREC): A prospective randomized, open-label, multicenter, phase II clinical trial.

Dysfunctional tumor-infiltrating Vδ1 + T lymphocytes in microsatellite-stable colorectal cancer

Cancer-associated fibroblasts shape early myeloid cell response to chemotherapy-induced immunogenic signals in next generation tumor organoid cultures

Prospective screening and proposed treatment algorithm for immune checkpoint inhibitor induced myositis in neoadjuvant-treated rectal cancer patients: data from the phase II CHINOREC trial

Von Willebrand Factor Antigen Improves Risk Stratification for Patients with a Diagnosis of Resectable Hepatocellular Carcinoma.

P04.04 Single cell transcriptomics reveals cancer associated fibroblasts enable modeling of tumor associated macrophage like phenotypes and treatment responses in primary colorectal cancer organoid cultures

Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration

Collaborators (5)

Hannes Stockinger

Henning Walczak

Oliver Pusch

Rudolf Oehler

Nina Pilat

Make your next move.